JAC Advance Access originally published online on November 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 893-898
© 2003 The British Society for Antimicrobial Chemotherapy
Review |
Pharmacological indices in antibiotic therapy
Pharmaceutical Microbiology, University of Bonn, Meckenheimer Allee 168, 53115 Bonn, Germany
After 60 years of antibiotic treatment, attempts to rationalize it have culminated in the use of pharmacological indices. These indices facilitate comparison of the activity of different antibiotics and serve as a sound basis for antibiotic dosing. Pharmacokinetic parameters (e.g. AUC, Cmax) and pharmacodynamic parameters (mostly MIC) are used for this purpose. For the so-called concentration-dependent antibiotics, the pharmacological indices AUC/MIC and Cmax/MIC are used, whereas for time-dependent antibiotics, the pharmacological index T>MIC is used. Some authors believe that the index AUC/MIC can be used as a universal index, but, not all experts accept this generalization. As the various pharmacological indices have been defined inconsistently in the literature, the International Society for Anti-Infective Pharmacology (ISAP) has published a paper on the terminology of pharmacokinetic and pharmacodynamic parameters and the pharmacological indices. This paper will help to ensure uniform use of terminology. In addition, we point out that the use of pharmacological indices should consider the differences in pharmacokinetics (patient characteristics and localization of the infection) and the differences in pharmacodynamics of antibiotics (beyond MICs) with different pathogens (e.g. Gram-positive and Gram-negative).
Keywords: pharmacokinetics, pharmacodynamics, Cmax/MIC, T>MIC, AUC/MIC
* Corresponding author. Tel: +49-228-735272; Fax: +49-228-735267; E-mail: B.Wiedemann{at}uni-bonn.de
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. K. Verma, J. Kaur, K. Kumar, A. B. Yadav, and A. Misra Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3195 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Garre, K. Shebany, A. Gryspeerdt, K. Baert, K. van der Meulen, H. Nauwynck, P. Deprez, P. De Backer, and S. Croubels Pharmacokinetics of Acyclovir after Intravenous Infusion of Acyclovir and after Oral Administration of Acyclovir and Its Prodrug Valacyclovir in Healthy Adult Horses Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4308 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. LaPlante and M. J. Rybak Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4665 - 4672. [Abstract] [Full Text] [PDF] |
||||
